ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Budget Impact Analysis of Chronic Myeloid Leukemia Treatment in Bulgaria
Biotechnology & Biotechnological Equipment
◽
10.5504/bbeq.2012.0075
◽
2013
◽
Vol 27
(1)
◽
pp. 3595-3598
◽
Cited By ~ 2
Author(s):
Alexandra Savova
◽
Maria Kamusheva
◽
Svetla Georgieva
◽
Assena Stoimenova
◽
Guenka Petrova
Keyword(s):
Chronic Myeloid Leukemia
◽
Myeloid Leukemia
◽
Impact Analysis
◽
Budget Impact
◽
Budget Impact Analysis
◽
Leukemia Treatment
Download Full-text
Related Documents
Cited By
References
PCN34 BUDGET IMPACT ANALYSIS OF DASATINIB IN PATIENTS WITH IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA (CML) IN BRAZIL
Value in Health
◽
10.1016/s1098-3015(10)74285-6
◽
2009
◽
Vol 12
(7)
◽
pp. A262
Author(s):
E Asano
◽
M Nita
◽
A Moellmann-Coelho
◽
R Rached
◽
B Donato
◽
...
Keyword(s):
Chronic Myeloid Leukemia
◽
Myeloid Leukemia
◽
Impact Analysis
◽
Budget Impact
◽
Budget Impact Analysis
◽
Imatinib Resistant
Download Full-text
The Budget Impact Analysis of Nilotinib in the Second-Line Treatment of Imatinib-Resistant or Intolerant Chronic Myeloid Leukemia
Value in Health
◽
10.1016/j.jval.2018.07.728
◽
2018
◽
Vol 21
◽
pp. S96
Author(s):
C Huang
◽
L Shen
◽
Y LIU
Keyword(s):
Chronic Myeloid Leukemia
◽
Myeloid Leukemia
◽
Impact Analysis
◽
Budget Impact
◽
Budget Impact Analysis
◽
Line Treatment
◽
Second Line
◽
Imatinib Resistant
Download Full-text
Budget Impact Analysis for Nilotinib Use in the Treatment of Chronic Myeloid Leukemia in Colombia
Value in Health
◽
10.1016/j.jval.2014.03.438
◽
2014
◽
Vol 17
(3)
◽
pp. A75
Author(s):
M. Romero
◽
G. Acero
◽
R. Marrugo
Keyword(s):
Chronic Myeloid Leukemia
◽
Myeloid Leukemia
◽
Impact Analysis
◽
Budget Impact
◽
Budget Impact Analysis
Download Full-text
Budget impact analysis for pharmacological therapy of chronic myeloid leukemia (cml) with nilotinib as the secondline treatment
Pharmacoeconomics theory and practice
◽
10.30809/phe.2.2015.12
◽
2015
◽
Vol 3
(2)
◽
pp. 109-114
Author(s):
V.G. Serpik
Keyword(s):
Chronic Myeloid Leukemia
◽
Myeloid Leukemia
◽
Impact Analysis
◽
Budget Impact
◽
Pharmacological Therapy
◽
Budget Impact Analysis
Download Full-text
Budget Impact Analysis of Dasatinib in Imatinib-Resistant Or-Intolerant Patients with Chronic Phase Chronic Myeloid Leukemia (Cml-Cp) in the Chinese Setting
Value in Health
◽
10.1016/j.jval.2016.08.304
◽
2016
◽
Vol 19
(7)
◽
pp. A881
Author(s):
B Wu
Keyword(s):
Chronic Myeloid Leukemia
◽
Myeloid Leukemia
◽
Impact Analysis
◽
Budget Impact
◽
Chronic Phase
◽
Budget Impact Analysis
◽
Imatinib Resistant
Download Full-text
Budget Impact Analysis or Pharmacological Therapy of Chronic Myeloid Leukemia (Cml) with Nilotinib as the Second-Line Treatment in Russian Federation
Value in Health
◽
10.1016/j.jval.2015.09.1089
◽
2015
◽
Vol 18
(7)
◽
pp. A442
Author(s):
VG Serpik
◽
R Yagudina
Keyword(s):
Chronic Myeloid Leukemia
◽
Russian Federation
◽
Myeloid Leukemia
◽
Impact Analysis
◽
Budget Impact
◽
Pharmacological Therapy
◽
Budget Impact Analysis
◽
Line Treatment
◽
Second Line
Download Full-text
Budget Impact Analysis of the Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors – Nilotinib in the First and Second Lines of Therapy
Value in Health
◽
10.1016/j.jval.2015.09.1095
◽
2015
◽
Vol 18
(7)
◽
pp. A443
Author(s):
A Kolbin
◽
M Frolov
◽
A Kurylev
◽
I Vilum
◽
Y Balykina
◽
...
Keyword(s):
Chronic Myeloid Leukemia
◽
Tyrosine Kinase
◽
Tyrosine Kinase Inhibitors
◽
Myeloid Leukemia
◽
Impact Analysis
◽
Kinase Inhibitors
◽
Budget Impact
◽
Budget Impact Analysis
Download Full-text
Budget impact analysis of treatment‐free remission in nilotinib‐treated Japanese chronic myeloid leukemia patients
Cancer Science
◽
10.1111/cas.14430
◽
2020
◽
Vol 111
(7)
◽
pp. 2526-2535
Author(s):
Kiyotaka Yamazaki
◽
Naohito Inagaki
◽
Daniel Moldaver
◽
Ricardo Viana
◽
Shinya Kimura
Keyword(s):
Chronic Myeloid Leukemia
◽
Myeloid Leukemia
◽
Impact Analysis
◽
Budget Impact
◽
Budget Impact Analysis
◽
Treatment Free Remission
Download Full-text
PCN101 Budget IMPACT Analysis of Treatment-Free Remission (TFR) of Nilotinib Therapy in Chronic Myeloid Leukemia (CML) Patients in the Brazilian Private Healthcare System (BPHS)
Value in Health
◽
10.1016/j.jval.2020.08.238
◽
2020
◽
Vol 23
◽
pp. S440
Author(s):
H. Kim
◽
L. Fahham
◽
N.G.T.D.Q. Hazarbassanov
◽
D. Vivona
Keyword(s):
Chronic Myeloid Leukemia
◽
Healthcare System
◽
Myeloid Leukemia
◽
Impact Analysis
◽
Budget Impact
◽
Budget Impact Analysis
◽
Private Healthcare
◽
Treatment Free Remission
Download Full-text
Azacitidine For The Treatment of Adult Patients (Age 65 or Older) with Acute Myeloid Leukemia And >30% Bone Marrow Blasts In Spain: Budget Impact Analysis
Value in Health
◽
10.1016/j.jval.2016.09.1354
◽
2016
◽
Vol 19
(7)
◽
pp. A581
Author(s):
T Caloto
◽
C Días Ferreira
◽
M Rafel
◽
G Rovira
Keyword(s):
Bone Marrow
◽
Acute Myeloid Leukemia
◽
Myeloid Leukemia
◽
Impact Analysis
◽
Budget Impact
◽
Budget Impact Analysis
◽
Adult Patients
◽
Bone Marrow Blasts
◽
Acute Myeloid
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close